THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COMMON STOCK
Total 13F shares
82,268,185
Share change
-1,175,962
Total reported value
$2,932,655,269
Put/Call ratio
74%
Price per share
$35.65
Number of holders
145
Value change
-$42,002,988
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q4 2013

As of 31 Dec 2013, THERAVANCE INC - COMMON STOCK (THRX) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,268,185 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., EAGLE ASSET MANAGEMENT INC, and Sectoral Asset Management Inc. This page lists 145 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.